Choosing the Right Pacing Mode in Heart Failure - The CHOICE Trial
CHOICE
CHOosing the rIght paCing Mode in Heart failurE : Should Heart Failure Patients With Bradycardia Receive Biventricular Pacemakers Rather Than Conventional Pacemakers?
1 other identifier
interventional
22
1 country
1
Brief Summary
The aim of the study is to see if biventricular pacemakers offer any advantage over conventional pacemakers in patients with heart failure who require pacemakers. The endpoints will be the 6 minute walking distance along with markers of cardiovascular function. The investigators' hypothesis is that biventricular pacing is preferable to conventional pacing in these heart failure patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable heart-failure
Started Sep 2009
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2009
CompletedFirst Posted
Study publicly available on registry
April 3, 2009
CompletedStudy Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedJuly 11, 2017
July 1, 2017
1 year
March 31, 2009
July 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6 minute hall walk test
Baseline, 3, 6, 9 and 12 months
Secondary Outcomes (2)
Endothelial Function
Baseline, 3, 6, 9 and 12 months
Cardiac Output
Baseline, 3, 6, 9 and 12 months
Study Arms (2)
1
EXPERIMENTALBiventricular Pacing
2
ACTIVE COMPARATORRight Ventricular Pacing
Interventions
Eligibility Criteria
You may qualify if:
- Left ventricular systolic dysfunction.
- Atrio-ventricular node disease.
- Anticipated to be more than 40% paced, (including patients in permanent atrial fibrillation).
- Ability to walk independently (walking aid permitted).
You may not qualify if:
- Patients meeting criteria for CRT by current guidelines will be excluded.
- Life expectancy less than12 months.
- Inability to walk independently.
- Patients not likely to be compliant with follow-up.
- Bradyarrhythmia due with sino-atrial disease only.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Dundeelead
- Chest, Heart and Stroke Association Scotlandcollaborator
- Abbott Medical Devicescollaborator
Study Sites (1)
Ninewells Hospital & Medical School
Dundee, UK, DD1 9SY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Anna Maria Choy
Study Record Dates
First Submitted
March 31, 2009
First Posted
April 3, 2009
Study Start
September 1, 2009
Primary Completion
September 1, 2010
Study Completion
January 1, 2011
Last Updated
July 11, 2017
Record last verified: 2017-07